Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2025-12-26 @ 12:30 AM
NCT ID: NCT02293460
Description: None
Frequency Threshold: 5
Time Frame: The safety was assessed by recording all AEs occurring during the study, i.e. after signature of the informed consent and until the end of the study recorded (week 24 after inclusion).
Study: NCT02293460
Study Brief: Efficacy and Safety Study of I10E in Treatment of Patients With CIDP
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Total Treated Set All subjects who received at least one infusion of I10E 0 None 7 43 39 43 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Femur fracture NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.1) View
Synovial rupture NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.1) View
Fibrin D dimer increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View
Colorectal adenocarcinoma NON_SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (17.1) View
Neutropenia NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (17.1) View
Anaphylactic reaction NON_SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA (17.1) View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Transient ischaemic attack NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Pancreatitis NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Oropharyngeal pain NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (17.1) View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Pyrexia NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Asthenia NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Malaise NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Rash NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.1) View
Urinary tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.1) View
Anaemia NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (17.1) View
Vertigo NON_SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders MedDRA (17.1) View
Chills NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Pruritus NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.1) View
Myalgia NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
Arthralgia NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
Influenza NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.1) View